Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 380Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3CITIUS PHARMS

02 24VIVUS LLC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PHENTERMINE HYDROCHLORIDE

US Patent Number : 8440170

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202088

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-14

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PHENTERMINE HYDROCHLORIDE

US Patent Number : 8440170

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202088

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-14

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PHENTERMINE HYDROCHLORIDE

US Patent Number : 8440170

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202088

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-14

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PHENTERMINE HYDROCHLORIDE; TOPIRAMATE

US Patent Number : 9011906

Drug Substance Claim :

Drug Product Claim :

Application Number : 22580

Patent Use Code : U-3398

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-09

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PHENTERMINE HYDROCHLORIDE; TOPIRAMATE

US Patent Number : 9011906

Drug Substance Claim :

Drug Product Claim :

Application Number : 22580

Patent Use Code : U-3398

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-09

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PHENTERMINE HYDROCHLORIDE; TOPIRAMATE

US Patent Number : 9011906

Drug Substance Claim :

Drug Product Claim :

Application Number : 22580

Patent Use Code : U-3398

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-09

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PHENTERMINE HYDROCHLORIDE; TOPIRAMATE

US Patent Number : 9011906

Drug Substance Claim :

Drug Product Claim :

Application Number : 22580

Patent Use Code : U-3398

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-09

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PHENTERMINE HYDROCHLORIDE; TOPIRAMATE

US Patent Number : 8895057

Drug Substance Claim :

Drug Product Claim :

Application Number : 22580

Patent Use Code : U-3398

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-09

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PHENTERMINE HYDROCHLORIDE; TOPIRAMATE

US Patent Number : 8895057

Drug Substance Claim :

Drug Product Claim :

Application Number : 22580

Patent Use Code : U-3398

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-09

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PHENTERMINE HYDROCHLORIDE; TOPIRAMATE

US Patent Number : 8895057

Drug Substance Claim :

Drug Product Claim :

Application Number : 22580

Patent Use Code : U-3398

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-09

blank